These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20566437)

  • 21. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
    Sinha VR; Mittal BR; Kumria R
    Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
    Toti US; Aminabhavi TM
    J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of budesonide compression-coated tablets for colonic delivery.
    Yehia SA; Elshafeey AH; Sayed I; Shehata AH
    AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
    Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compression coated systems for colonic delivery of 5-fluorouracil.
    Sinha VR; Singh A; Singh S; Bhinge JR
    J Pharm Pharmacol; 2007 Mar; 59(3):359-65. PubMed ID: 17331338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of natural polymer coating on novel colon targeting drug delivery system.
    Ravi V; Siddaramaiah ; Pramod Kumar TM
    J Mater Sci Mater Med; 2008 May; 19(5):2131-6. PubMed ID: 17999035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery.
    Prasad YV; Krishnaiah YS; Satyanarayana S
    J Control Release; 1998 Feb; 51(2-3):281-7. PubMed ID: 9685926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.
    Lai H; Lin K; Zhang W; Zhang Z; Jie L; Wu Y; He Q
    Drug Dev Ind Pharm; 2010 Jan; 36(1):81-92. PubMed ID: 19640246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin.
    Ji C; Xu H; Wu W
    J Drug Target; 2007 Feb; 15(2):123-31. PubMed ID: 17365283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polysaccharide matrices for microbially triggered drug delivery to the colon.
    Sinha VR; Kumria R
    Drug Dev Ind Pharm; 2004 Feb; 30(2):143-50. PubMed ID: 15089048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of hydrogel-based controlled-release niacin tablets.
    Khullar P; Khar RK; Agarwal SP
    Drug Dev Ind Pharm; 1998 May; 24(5):479-83. PubMed ID: 9876611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro and In-vivo Pharmacokinetic Evaluation of Guar Gum-Eudragit® S100 Based Colon-targeted Spheroids of Sulfasalazine Co-administered with Probiotics.
    Sharma A; Kumar B; Singh SK; Gulati M; Vaidya Y; ; Rathee H; Ghai D; Malik AH; Yadav AK; Maharshi P; Bawa P; Rajesh SY; Sharma P; Pandey NK; Mohanta S
    Curr Drug Deliv; 2018; 15(3):367-387. PubMed ID: 29219056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colon targeted guar gum compression coated tablets of flurbiprofen: formulation, development, and pharmacokinetics.
    Vemula SK; Bontha VK
    Biomed Res Int; 2013; 2013():287919. PubMed ID: 24260738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery.
    Tuğcu-Demiröz F; Acartürk F; Takka S; Konuş-Boyunağa O
    J Drug Target; 2004 Feb; 12(2):105-12. PubMed ID: 15203904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation development and in-vitro/in-vivo correlation for a novel Sterculia gum-based oral colon-targeted drug delivery system of azathioprine.
    Nath B; Nath LK
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1765-73. PubMed ID: 23110370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.